Effectiveness of NeoMayor in Improving Cardiovascular Health in Chilean Older Adults

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-75
SponsorUniversity of Chile

About this trial

This study aims to evaluate the effectiveness of NeoMayor, a mobile health (mHealth) intervention designed to improve cardiovascular health among older adults at elevated cardiovascular risk in Chile. NeoMayor is a smartphone-based application that provides personalized guidance on physical activity, diet, sleep, and mental well-being through a multidomain lifestyle approach.

This multicenter randomized controlled trial will enroll community-dwelling older adults aged 55 to 75 years recruited from primary healthcare centers in urban and rural settings. Participants will be randomized in a 2:1 ratio to either the NeoMayor intervention or a control group receiving standard health information and usual care. The intervention duration will be four months.

The primary objective is to determine whether the NeoMayor intervention improves cardiovascular health as measured by the Life's Essential 8 Cardiovascular Health Index. Secondary objectives include evaluating changes in cognitive performance, depressive symptoms, anxiety symptoms, quality of life and physical performance outcomes. The study will also assess feasibility and adherence to digital intervention.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 55 and 75 years

Able to read and understand written instructions

Ownership of a smartphone and ability to use it independently

Physically inactive, defined as performing less than 30 minutes of daily physical activity or less than 2,5 h a week.

Disqualifiers

Dementia defined as a score in the MEFO < 9

Significant limitations for independent mobility, including use of assistive devices, frailty, gait instability, or lower-limb painful conditions limiting physical activity

Uncorrected hearing or visual impairment preventing adequate use of a smartphone

Chronic neurological, psychiatric, or psychological disorders without regular treatment or follow-up.

Trial design

Design model

Parallel

Treatments tested in this trial

  • NeoMayor App

    Behavioral

    NeoMayor is a smartphone-based multidomain lifestyle intervention designed for older adults. The application delivers structured behavioral challenges and personalized recommendations targeting physical activity, healthy diet, sleep quality, and emotional well-being. Participants receive onboarding training and ongoing app-based feedback throughout the 4-month intervention period.

  • Wearable Device Support

    Device

    Participants randomized to wearable support will receive a commercially available wearable activity tracker synchronized with the NeoMayor application to support self-monitoring of physical activity and health behaviors.

  • Human Health Coach Support

    Behavioral

    Participants randomized to coach support will receive monthly contact from a geriatrician to support onboarding, troubleshoot app use, and encourage continued engagement with the app content and challenges. This is an implementation support strategy, not an independent clinical intervention.

Treatment groups

240 Participants
are divided into 2 treatment groups
Group A: NeoMayor appExperimental treatment 3 interventions
Group B: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Change in Life's Essential 8 Cardiovascular Health Index (CVHI)

The primary outcome is the change in the American Heart Association Life's Essential 8 Cardiovascular Health Index (CVHI) from baseline to 4 months. The CVHI is a composite score ranging from 0 to 100, with higher scores indicating better outcome. The score is calculated as the unweighted average of eight cardiovascular health components: smoking status, physical activity, diet quality, sleep duration, body mass index, blood pressure, LDL cholesterol, and fasting glucose. Each component is scored from 0 to 100 according to the American Heart Association scoring algorithm, with higher scores indicating better cardiovascular health.

Time frame
Baseline and 4 months

Secondary outcomes

1

Cognitive performance

Cognitive performance will be assessed by 3 different test: The Mini-Addenbrooke's Cognitive Examination (scores 0-30, higher scores are better) for global cognition. Trail Making Test - Black \& White A \& B (scores 0-300 sec, ,higher is worse) for attention and cognitive flexibility and the Digit Symbol Substitution Test (DSST) (scores 0-130, higher is better) for processing speed.

Time frame
Baseline and 4 months
2

Depression

Yesavage Geriatric depression scale 15 (scores 0-15) higher is worse

Time frame
Baseline and 4 months
3

Anxiety

Geriatric Anxiety Inventory (scores 0-20) higher is worse

Time frame
Baseline and 4 months
4

Health-Related Quality of Life

Health-Related Quality of Life -12 (scores 0-100) higher is better

Time frame
Baseline and 4 months

Other outcomes

1

Engagement

Number of app sessions, session frequency, total time in-app

Time frame
Continuous over 4 months
2

Adherence

Percentage of prescribed challenges completed; proportion of planned activities completed

Time frame
: Continuous over 4 months
3

Retention

Proportion of participants remaining active in the intervention through 4 months

Time frame
4 months
4

Maintenance of app use

App use frequency in the final month compared with the first month.

Time frame
Month 1 and Month 4

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Chile

Lead sponsor

Agencia Nacional de Investigación y Desarrollo

Collaborator

This trial is not recruiting at the moment. You can still explore other options: